$GTBIF
Green Thumb Industries Inc. Stock $gtbif

$gtbif Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000095017024022653 Filed on February 29, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$278.2M	$1.055B
YoY Change	7.31%	3.65%
Cost Of Revenue	$135.5M	$528.1M
YoY Change	0.19%	2.85%
Gross Profit	$142.7M	$526.5M
YoY Change	15.08%	4.47%
Gross Profit Margin	51.28%	49.93%
Selling, General & Admin	$86.88M	$341.9M
YoY Change	10.57%	16.12%
% of Gross Profit	60.89%	64.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$27.43M	$100.8M
YoY Change	9.89%	4.27%
% of Gross Profit	19.22%	19.14%
Operating Expenses	$86.88M	$341.9M
YoY Change	10.57%	-10.72%
Operating Profit	$50.34M	$184.6M
YoY Change	-213.09%	52.51%
Interest Expense	-$23.09M	$19.07M
YoY Change	-77076.67%	-10.04%
% of Operating Profit	-45.87%	10.33%
Other Income/Expense, Net	-$310.0K	-$28.58M
YoY Change	-97.8%	126.27%
Pretax Income	$28.22M	$156.0M
YoY Change	-148.18%	43.91%
Income Tax	$24.70M	$118.6M
% Of Pretax Income	87.54%	76.02%
Net Earnings	$3.216M	$36.27M
YoY Change	-106.28%	202.78%
Net Earnings / Revenue	1.16%	3.44%
Basic Earnings Per Share	$0.01	$0.15
Diluted Earnings Per Share	$0.01	$0.15
COMMON SHARES
Basic Shares Outstanding	236.9M	237.9M
Diluted Shares Outstanding	239.2M	239.8M

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$161.6M	$161.6M
YoY Change	-9.03%	-9.03%
Cash & Equivalents	$161.6M	$161.6M
Short-Term Investments
Other Short-Term Assets	$5.382M	$25.18M
YoY Change	-12.94%	28.84%
Inventory	$113.0M	$113.0M
Prepaid Expenses	$19.80M
Receivables	$42.98M	$42.98M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$342.8M	$342.8M
YoY Change	-2.44%	-2.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$687.1M	$925.5M
YoY Change	23.17%	15.65%
Goodwill	$589.7M
YoY Change	0.0%
Intangibles	$538.7M
YoY Change	-8.62%
Long-Term Investments	$89.30M	$89.30M
YoY Change	-10.41%	-10.41%
Other Assets	$3.598M	$3.598M
YoY Change	17.58%	17.58%
Total Long-Term Assets	$2.147B	$2.147B
YoY Change	3.13%	3.13%
TOTAL ASSETS
Total Short-Term Assets	$342.8M	$342.8M
Total Long-Term Assets	$2.147B	$2.147B
Total Assets	$2.490B	$2.490B
YoY Change	2.32%	2.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.50M	$24.50M
YoY Change	32.96%	32.96%
Accrued Expenses	$59.55M	$87.85M
YoY Change	-31.53%	-21.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.996M	$2.996M
YoY Change	188.91%	188.91%
Total Short-Term Liabilities	$126.1M	$126.1M
YoY Change	-14.0%	-14.0%
LONG-TERM LIABILITIES
Long-Term Debt	$305.5M	$305.5M
YoY Change	11.25%	11.25%
Other Long-Term Liabilities	$282.7M	$282.7M
YoY Change	-0.57%	-0.57%
Total Long-Term Liabilities	$588.2M	$588.2M
YoY Change	5.24%	5.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$126.1M	$126.1M
Total Long-Term Liabilities	$588.2M	$588.2M
Total Liabilities	$786.8M	$787.2M
YoY Change	2.44%	2.42%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.703B	$1.703B
YoY Change
Total Liabilities & Shareholders Equity	$2.490B	$2.490B
YoY Change	2.32%	2.32%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$3.216M	$36.27M
YoY Change	-106.28%	202.78%
Depreciation, Depletion And Amortization	$27.43M	$100.8M
YoY Change	9.89%	4.27%
Cash From Operating Activities	$71.10M	$225.0M
YoY Change	1.07%	41.88%
INVESTING ACTIVITIES
Capital Expenditures	$36.44M	$220.0M
YoY Change	552.6%	22.58%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$4.023M	-$7.873M
YoY Change	-572.18%	-80.53%
Cash From Investing Activities	-$40.46M	-$227.9M
YoY Change	-31.16%	3.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.840M	-13.11M
YoY Change	-130.97%	-251.64%
NET CHANGE
Cash From Operating Activities	71.10M	225.0M
Cash From Investing Activities	-40.46M	-227.9M
Cash From Financing Activities	-5.840M	-13.11M
Net Change In Cash	24.79M	-16.05M
YoY Change	-18.51%	-69.57%
FREE CASH FLOW
Cash From Operating Activities	$71.10M	$225.0M
Capital Expenditures	$36.44M	$220.0M
Free Cash Flow	$34.65M	$4.933M
YoY Change	-46.49%	-123.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001795139
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	gtbif	Cash Consideration Receivable CashConsiderationReceivable
CY2021	gtbif	Cash Consideration Receivable CashConsiderationReceivable
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56132
CY2023	dei	Entity Registrant Name EntityRegistrantName	GREEN THUMB INDUSTRIES INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1437430
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	325 West Huron Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60654
CY2023	dei	City Area Code CityAreaCode	312
CY2023	dei	Local Phone Number LocalPhoneNumber	471-6720
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1628045000
CY2023Q4	us-gaap	Assets Assets	2490057000
CY2022Q4	us-gaap	Assets Assets	2433528000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	24495000
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	23
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	161634000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177682000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42975000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30975000
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7473000
CY2023Q4	us-gaap	Inventory Net InventoryNet	112970000
CY2022Q4	us-gaap	Inventory Net InventoryNet	115675000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19801000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13364000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5382000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6182000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	342762000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	351351000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	687106000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	557873000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	238369000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	242357000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	64361000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	74169000
CY2023Q4	gtbif	Investment In Associate InvestmentInAssociate	24942000
CY2022Q4	gtbif	Investment In Associate InvestmentInAssociate	25508000
CY2023Q4	gtbif	Note Receivable NoteReceivable	550000
CY2022Q4	gtbif	Note Receivable NoteReceivable	0
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	538678000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	589519000
CY2023Q4	us-gaap	Goodwill Goodwill	589691000
CY2022Q4	us-gaap	Goodwill Goodwill	589691000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1041000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0
CY2023Q4	gtbif	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	2557000
CY2022Q4	gtbif	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3060000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	18423000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	59552000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	86971000
CY2023Q4	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	16005000
CY2022Q4	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	13476000
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2996000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1037000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12297000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10906000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	11400000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10705000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4358000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	126050000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	146571000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	249464000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	249281000
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	305527000
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	274631000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	33250000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	30543000
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	0
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	4520000
CY2023Q4	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	72510000
CY2022Q4	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	62550000
CY2023Q4	us-gaap	Liabilities Liabilities	786801000
CY2022Q4	us-gaap	Liabilities Liabilities	768096000
CY2023Q4	gtbif	Common Stock Value Issued CommonStockValueIssued	1703852000
CY2022Q4	gtbif	Common Stock Value Issued CommonStockValueIssued	1663557000
CY2023Q4	gtbif	Contributed Surplus ContributedSurplus	7871000
CY2022Q4	gtbif	Contributed Surplus ContributedSurplus	23233000
CY2023Q4	gtbif	Issuance Of Deferred Shares IssuanceOfDeferredShares	12973000
CY2022Q4	gtbif	Issuance Of Deferred Shares IssuanceOfDeferredShares	36211000
CY2023Q4	gtbif	Accumulated Deficit AccumulatedDeficit	-21818000
CY2022Q4	gtbif	Accumulated Deficit AccumulatedDeficit	-58085000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1702878000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1664916000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	378000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	516000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1703256000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1665432000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2490057000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2433528000
CY2023	us-gaap	Revenues Revenues	1054553000
CY2022	us-gaap	Revenues Revenues	1017375000
CY2021	us-gaap	Revenues Revenues	893560000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	528058000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	513412000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	401631000
CY2023	us-gaap	Gross Profit GrossProfit	526495000
CY2022	us-gaap	Gross Profit GrossProfit	503963000
CY2021	us-gaap	Gross Profit GrossProfit	491929000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	341863000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	294396000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	277087000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	88503000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2023	us-gaap	Operating Expenses OperatingExpenses	341863000
CY2022	us-gaap	Operating Expenses OperatingExpenses	382899000
CY2021	us-gaap	Operating Expenses OperatingExpenses	277087000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	184632000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	121064000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	214842000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16207000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4499000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10677000
CY2023	us-gaap	Interest Income Other InterestIncomeOther	6697000
CY2022	us-gaap	Interest Income Other InterestIncomeOther	4070000
CY2021	us-gaap	Interest Income Other InterestIncomeOther	1432000
CY2023	us-gaap	Interest Expense InterestExpense	19073000
CY2022	us-gaap	Interest Expense InterestExpense	21201000
CY2021	us-gaap	Interest Expense InterestExpense	21976000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28583000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12632000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9867000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	156049000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108432000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	204975000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118630000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94777000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124612000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	37419000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	13655000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	80363000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1152000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1677000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4927000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	36267000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11978000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	75436000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237927867
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236713056
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223192326
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239827390
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238080030
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	226758882
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	914158000
CY2021	gtbif	Issuance Of Shares Under Business Combinations And Investments IssuanceOfSharesUnderBusinessCombinationsAndInvestments	343303000
CY2021	gtbif	Stock Issued During Period Value Distribution Of Contingent Consideration StockIssuedDuringPeriodValueDistributionOfContingentConsideration	33472000
CY2021	gtbif	Issuance Of Deferred Share IssuanceOfDeferredShare	37565000
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	6000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	155498000
CY2021	gtbif	Stock Issued During Period Value Options Exercise Restricted Stock Units And Warrants StockIssuedDuringPeriodValueOptionsExerciseRestrictedStockUnitsAndWarrants	14260000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	19600000
CY2021	gtbif	Issuance Of Warrants And Shares In Association With Notes Payable IssuanceOfWarrantsAndSharesInAssociationWithNotesPayable	25146000
CY2021	gtbif	Proceeds From Shares Issued For Settlement Of Business Dispute ProceedsFromSharesIssuedForSettlementOfBusinessDispute	7135000
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	11028000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	80363000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1619478000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1619478000
CY2022	gtbif	Issuance Of Shares Under Business Combinations And Investments IssuanceOfSharesUnderBusinessCombinationsAndInvestments	1406000
CY2022	gtbif	Stock Issued During Period Value Distribution Of Contingent Consideration StockIssuedDuringPeriodValueDistributionOfContingentConsideration	13111000
CY2022	gtbif	Indemnification Of Deferred Shares Associated With Post Acquisition Costs IndemnificationOfDeferredSharesAssociatedWithPostAcquisitionCosts	-51000
CY2022	gtbif	Stock Issued During Period Value Options Exercise Restricted Stock Units And Warrants StockIssuedDuringPeriodValueOptionsExerciseRestrictedStockUnitsAndWarrants	3822000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	27140000
CY2022	gtbif	Proceeds From Shares Issued For Settlement Of Business Dispute ProceedsFromSharesIssuedForSettlementOfBusinessDispute	1750000
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14879000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	13655000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1665432000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1665432000
CY2023	gtbif	Stock Issued During Period Contingent Consideration Amount StockIssuedDuringPeriodContingentConsiderationAmount	12524000
CY2023	gtbif	Indemnification Of Deferred Shares Associated With Post Acquisition Costs IndemnificationOfDeferredSharesAssociatedWithPostAcquisitionCosts	-2784000
CY2023	gtbif	Stock Issued During Period Value Options Exercise Restricted Stock Units And Warrants StockIssuedDuringPeriodValueOptionsExerciseRestrictedStockUnitsAndWarrants	3622000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	28189000
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1290000
CY2023	gtbif	Repurchase Of Subordinate Voting Shares RepurchaseOfSubordinateVotingShares	39856000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	37419000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1703256000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	36267000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11978000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	75436000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1152000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1677000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4927000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100790000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	96664000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68458000
CY2023	gtbif	Amortization Of Operating Lease Assets AmortizationOfOperatingLeaseAssets	48231000
CY2022	gtbif	Amortization Of Operating Lease Assets AmortizationOfOperatingLeaseAssets	43985000
CY2021	gtbif	Amortization Of Operating Lease Assets AmortizationOfOperatingLeaseAssets	34124000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1283000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10645000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3542000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-383000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-314000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	88503000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	5467000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1419000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4744000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1166000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4259000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1799000
CY2023	gtbif	Gain From Lease Modification GainFromLeaseModification	52000
CY2022	gtbif	Gain From Lease Modification GainFromLeaseModification	-3330000
CY2021	gtbif	Gain From Lease Modification GainFromLeaseModification	0
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	8918000
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-17477000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4763000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	28189000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	27140000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	19600000
CY2023	gtbif	Increase Decrease In Fair Value Of Investments IncreaseDecreaseInFairValueOfInvestments	17460000
CY2022	gtbif	Increase Decrease In Fair Value Of Investments IncreaseDecreaseInFairValueOfInvestments	11651000
CY2021	gtbif	Increase Decrease In Fair Value Of Investments IncreaseDecreaseInFairValueOfInvestments	-6377000
CY2023	gtbif	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	-3831000
CY2022	gtbif	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	29012000
CY2021	gtbif	Increase Decrease In Fair Value Of Contingent Consideration IncreaseDecreaseInFairValueOfContingentConsideration	8273000
CY2023	gtbif	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	1403000
CY2022	gtbif	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	20357000
CY2021	gtbif	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	14577000
CY2023	gtbif	Proceeds From Shares Issued For Settlement Of Business Dispute ProceedsFromSharesIssuedForSettlementOfBusinessDispute	0
CY2022	gtbif	Proceeds From Shares Issued For Settlement Of Business Dispute ProceedsFromSharesIssuedForSettlementOfBusinessDispute	1750000
CY2021	gtbif	Proceeds From Shares Issued For Settlement Of Business Dispute ProceedsFromSharesIssuedForSettlementOfBusinessDispute	7135000
CY2023	gtbif	Gain On Indemnification Of Deferred Shares GainOnIndemnificationOfDeferredShares	2784000
CY2022	gtbif	Gain On Indemnification Of Deferred Shares GainOnIndemnificationOfDeferredShares	51000
CY2021	gtbif	Gain On Indemnification Of Deferred Shares GainOnIndemnificationOfDeferredShares	0
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9718000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9174000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7235000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12000000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8841000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	158000
CY2023	gtbif	Increase Decrease In Inventory IncreaseDecreaseInInventory	-2615000
CY2022	gtbif	Increase Decrease In Inventory IncreaseDecreaseInInventory	19791000
CY2021	gtbif	Increase Decrease In Inventory IncreaseDecreaseInInventory	16439000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5603000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3222000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4863000
CY2023	gtbif	Increase Decrease In Deposits And Other Assets IncreaseDecreaseInDepositsAndOtherAssets	-503000
CY2022	gtbif	Increase Decrease In Deposits And Other Assets IncreaseDecreaseInDepositsAndOtherAssets	419000
CY2021	gtbif	Increase Decrease In Deposits And Other Assets IncreaseDecreaseInDepositsAndOtherAssets	749000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6072000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3571000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9525000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2969000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2412000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10165000
CY2023	gtbif	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	42721000
CY2022	gtbif	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	38258000
CY2021	gtbif	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	28597000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13820000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5244000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-14615000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	224968000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	158564000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	132048000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	220035000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	179500000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	187850000
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	429000
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	869000
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	109000
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8800000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5804000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	79050000
CY2023	gtbif	Proceeds From Equity Investments And Notes Receivable ProceedsFromEquityInvestmentsAndNotesReceivable	498000
CY2022	gtbif	Proceeds From Equity Investments And Notes Receivable ProceedsFromEquityInvestmentsAndNotesReceivable	3571000
CY2021	gtbif	Proceeds From Equity Investments And Notes Receivable ProceedsFromEquityInvestmentsAndNotesReceivable	18417000
CY2023	gtbif	Settlement Of Acquisition Consideration Payable SettlementOfAcquisitionConsiderationPayable	0
CY2022	gtbif	Settlement Of Acquisition Consideration Payable SettlementOfAcquisitionConsiderationPayable	-31732000
CY2021	gtbif	Settlement Of Acquisition Consideration Payable SettlementOfAcquisitionConsiderationPayable	0
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7350000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	32356000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-227908000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-219946000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-280730000
CY2023	gtbif	Contributions From Limited Liability Company Unit Holders ContributionsFromLimitedLiabilityCompanyUnitHolders	0
CY2022	gtbif	Contributions From Limited Liability Company Unit Holders ContributionsFromLimitedLiabilityCompanyUnitHolders	0
CY2021	gtbif	Contributions From Limited Liability Company Unit Holders ContributionsFromLimitedLiabilityCompanyUnitHolders	1675000
CY2023	gtbif	Distributions To Third Parties And Limited Liability Company Unit Holders DistributionsToThirdPartiesAndLimitedLiabilityCompanyUnitHolders	1290000
CY2022	gtbif	Distributions To Third Parties And Limited Liability Company Unit Holders DistributionsToThirdPartiesAndLimitedLiabilityCompanyUnitHolders	14879000
CY2021	gtbif	Distributions To Third Parties And Limited Liability Company Unit Holders DistributionsToThirdPartiesAndLimitedLiabilityCompanyUnitHolders	11028000
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	550000
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	155498000
CY2023	gtbif	Repurchase Of Subordinate Voting Shares RepurchaseOfSubordinateVotingShares	39856000
CY2022	gtbif	Repurchase Of Subordinate Voting Shares RepurchaseOfSubordinateVotingShares	0
CY2021	gtbif	Repurchase Of Subordinate Voting Shares RepurchaseOfSubordinateVotingShares	0
CY2023	gtbif	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	3622000
CY2022	gtbif	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	3822000
CY2021	gtbif	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	14260000
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	49901000
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	20101000
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	208700000
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25485000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	950000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	70507000
CY2023	gtbif	Prepayment Penalty And Other Costs Associated With Refinancing PrepaymentPenaltyAndOtherCostsAssociatedWithRefinancing	0
CY2022	gtbif	Prepayment Penalty And Other Costs Associated With Refinancing PrepaymentPenaltyAndOtherCostsAssociatedWithRefinancing	0
CY2021	gtbif	Prepayment Penalty And Other Costs Associated With Refinancing PrepaymentPenaltyAndOtherCostsAssociatedWithRefinancing	-3254000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13108000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8644000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	295344000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16048000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-52738000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	146662000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	177682000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	230420000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	83758000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	161634000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	177682000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	230420000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	20912000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	18552000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	15311000
CY2023	gtbif	Accrued Capital Expenditures AccruedCapitalExpenditures	-30966000
CY2022	gtbif	Accrued Capital Expenditures AccruedCapitalExpenditures	887000
CY2021	gtbif	Accrued Capital Expenditures AccruedCapitalExpenditures	22096000
CY2023	gtbif	Noncash Increase In Right Of Use Asset NoncashIncreaseInRightOfUseAsset	7174000
CY2022	gtbif	Noncash Increase In Right Of Use Asset NoncashIncreaseInRightOfUseAsset	74996000
CY2021	gtbif	Noncash Increase In Right Of Use Asset NoncashIncreaseInRightOfUseAsset	27035000
CY2023	gtbif	Noncash Increase In Lease Liability NoncashIncreaseInLeaseLiability	-7174000
CY2022	gtbif	Noncash Increase In Lease Liability NoncashIncreaseInLeaseLiability	-74996000
CY2021	gtbif	Noncash Increase In Lease Liability NoncashIncreaseInLeaseLiability	-27035000
CY2023	gtbif	Warrant Issuance Associated With Note Payable WarrantIssuanceAssociatedWithNotePayable	0
CY2022	gtbif	Warrant Issuance Associated With Note Payable WarrantIssuanceAssociatedWithNotePayable	0
CY2021	gtbif	Warrant Issuance Associated With Note Payable WarrantIssuanceAssociatedWithNotePayable	25145000
CY2023	gtbif	Mortgages Associated With Dispensaries MortgagesAssociatedWithDispensaries	0
CY2022	gtbif	Mortgages Associated With Dispensaries MortgagesAssociatedWithDispensaries	7350000
CY2021	gtbif	Mortgages Associated With Dispensaries MortgagesAssociatedWithDispensaries	6830000
CY2023	gtbif	Share Issued For Purchase Of Non Controlling Interest ShareIssuedForPurchaseOfNonControllingInterest	0
CY2022	gtbif	Share Issued For Purchase Of Non Controlling Interest ShareIssuedForPurchaseOfNonControllingInterest	2379000
CY2021	gtbif	Share Issued For Purchase Of Non Controlling Interest ShareIssuedForPurchaseOfNonControllingInterest	4070000
CY2023	us-gaap	Stock Issued1 StockIssued1	12524000
CY2022	us-gaap	Stock Issued1 StockIssued1	13111000
CY2021	us-gaap	Stock Issued1 StockIssued1	33472000
CY2023	gtbif	Deferred Share Issuances To Prior Owners Of Noncontrolling Interest DeferredShareIssuancesToPriorOwnersOfNoncontrollingInterest	-0
CY2022	gtbif	Deferred Share Issuances To Prior Owners Of Noncontrolling Interest DeferredShareIssuancesToPriorOwnersOfNoncontrollingInterest	0
CY2021	gtbif	Deferred Share Issuances To Prior Owners Of Noncontrolling Interest DeferredShareIssuancesToPriorOwnersOfNoncontrollingInterest	-37565000
CY2023	gtbif	Deferred Share Distributions DeferredShareDistributions	-20454000
CY2022	gtbif	Deferred Share Distributions DeferredShareDistributions	0
CY2021	gtbif	Deferred Share Distributions DeferredShareDistributions	-3890000
CY2023	gtbif	Issuance Of Shares Under Business Combinations IssuanceOfSharesUnderBusinessCombinations	0
CY2022	gtbif	Issuance Of Shares Under Business Combinations IssuanceOfSharesUnderBusinessCombinations	1406000
CY2021	gtbif	Issuance Of Shares Under Business Combinations IssuanceOfSharesUnderBusinessCombinations	343303000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	90000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	412000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	9489000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1 NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1 NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1	34000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1 NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1	527000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	16000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	72000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	1117000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	447000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	738000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	30789000
CY2023	gtbif	Noncash Or Part Noncash Acquisition Right Of Use Assets NoncashOrPartNoncashAcquisitionRightOfUseAssets	128000
CY2022	gtbif	Noncash Or Part Noncash Acquisition Right Of Use Assets NoncashOrPartNoncashAcquisitionRightOfUseAssets	743000
CY2021	gtbif	Noncash Or Part Noncash Acquisition Right Of Use Assets NoncashOrPartNoncashAcquisitionRightOfUseAssets	19003000
CY2023	gtbif	Noncash Or Part Noncash Acquisition Acquired Increase And Decrease Goodwill NoncashOrPartNoncashAcquisitionAcquiredIncreaseAndDecreaseGoodwill	0
CY2022	gtbif	Noncash Or Part Noncash Acquisition Acquired Increase And Decrease Goodwill NoncashOrPartNoncashAcquisitionAcquiredIncreaseAndDecreaseGoodwill	4816000
CY2021	gtbif	Noncash Or Part Noncash Acquisition Acquired Increase And Decrease Goodwill NoncashOrPartNoncashAcquisitionAcquiredIncreaseAndDecreaseGoodwill	314457000
CY2023	gtbif	Non Cash Or Part Noncash Acquisition Goodwill NonCashOrPartNoncashAcquisitionGoodwill	0
CY2022	gtbif	Non Cash Or Part Noncash Acquisition Goodwill NonCashOrPartNoncashAcquisitionGoodwill	14214000
CY2021	gtbif	Non Cash Or Part Noncash Acquisition Goodwill NonCashOrPartNoncashAcquisitionGoodwill	250152000
CY2023	gtbif	Noncash Or Part Noncash Acquisition Deposits And Other Assets NoncashOrPartNoncashAcquisitionDepositsAndOtherAssets	0
CY2022	gtbif	Noncash Or Part Noncash Acquisition Deposits And Other Assets NoncashOrPartNoncashAcquisitionDepositsAndOtherAssets	12000
CY2021	gtbif	Noncash Or Part Noncash Acquisition Deposits And Other Assets NoncashOrPartNoncashAcquisitionDepositsAndOtherAssets	1031000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	3000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	1222000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	13692000
CY2023	gtbif	Noncash Or Part Noncash Acquisition Lease Liabilities NoncashOrPartNoncashAcquisitionLeaseLiabilities	-128000
CY2022	gtbif	Noncash Or Part Noncash Acquisition Lease Liabilities NoncashOrPartNoncashAcquisitionLeaseLiabilities	-743000
CY2021	gtbif	Noncash Or Part Noncash Acquisition Lease Liabilities NoncashOrPartNoncashAcquisitionLeaseLiabilities	-19003000
CY2023	gtbif	Non Cash Or Part Noncash Acquisition Notes Payable NonCashOrPartNoncashAcquisitionNotesPayable	0
CY2022	gtbif	Non Cash Or Part Noncash Acquisition Notes Payable NonCashOrPartNoncashAcquisitionNotesPayable	0
CY2021	gtbif	Non Cash Or Part Noncash Acquisition Notes Payable NonCashOrPartNoncashAcquisitionNotesPayable	5627000
CY2023Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	0
CY2022Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	17735000
CY2021Q4	us-gaap	Partners Capital Attributable To Noncontrolling Interest PartnersCapitalAttributableToNoncontrollingInterest	0
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	200000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	98500000
CY2023	gtbif	Non Cash Or Part Noncash Acquisition Equity Interests Issued NonCashOrPartNoncashAcquisitionEquityInterestsIssued	0
CY2022	gtbif	Non Cash Or Part Noncash Acquisition Equity Interests Issued NonCashOrPartNoncashAcquisitionEquityInterestsIssued	3785000
CY2021	gtbif	Non Cash Or Part Noncash Acquisition Equity Interests Issued NonCashOrPartNoncashAcquisitionEquityInterestsIssued	374244000
CY2023	gtbif	Fair Value Of Previously Held Equity Interest FairValueOfPreviouslyHeldEquityInterest	0
CY2022	gtbif	Fair Value Of Previously Held Equity Interest FairValueOfPreviouslyHeldEquityInterest	-11336000
CY2021	gtbif	Fair Value Of Previously Held Equity Interest FairValueOfPreviouslyHeldEquityInterest	0
CY2023	gtbif	Cash Consideration Payable CashConsiderationPayable	0
CY2022	gtbif	Cash Consideration Payable CashConsiderationPayable	0
CY2021	gtbif	Cash Consideration Payable CashConsiderationPayable	-32092000
CY2023	gtbif	Cash Consideration Receivable CashConsiderationReceivable	550000
CY2023	gtbif	Noncash Or Part Noncash Acquisition Deferred Income Taxes NoncashOrPartNoncashAcquisitionDeferredIncomeTaxes	-0
CY2022	gtbif	Noncash Or Part Noncash Acquisition Deferred Income Taxes NoncashOrPartNoncashAcquisitionDeferredIncomeTaxes	-1216000
CY2021	gtbif	Noncash Or Part Noncash Acquisition Deferred Income Taxes NoncashOrPartNoncashAcquisitionDeferredIncomeTaxes	51051000
CY2023	gtbif	Settlement Of Noncontrolling Interests SettlementOfNoncontrollingInterests	0
CY2022	gtbif	Settlement Of Noncontrolling Interests SettlementOfNoncontrollingInterests	-15356000
CY2021	gtbif	Settlement Of Noncontrolling Interests SettlementOfNoncontrollingInterests	0
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	7350000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	32356000
CY2023	gtbif	Decrease Increase In Fair Value Of Investments DecreaseIncreaseInFairValueOfInvestments	17460000
CY2022	gtbif	Decrease Increase In Fair Value Of Investments DecreaseIncreaseInFairValueOfInvestments	22606000
CY2021	gtbif	Decrease Increase In Fair Value Of Investments DecreaseIncreaseInFairValueOfInvestments	-6377000
CY2023	gtbif	Increase In Fair Value Of Equity Method Investments IncreaseInFairValueOfEquityMethodInvestments	0
CY2022	gtbif	Increase In Fair Value Of Equity Method Investments IncreaseInFairValueOfEquityMethodInvestments	-10955000
CY2021	gtbif	Increase In Fair Value Of Equity Method Investments IncreaseInFairValueOfEquityMethodInvestments	0
CY2023	gtbif	Increase In Fair Value Of Investments IncreaseInFairValueOfInvestments	17460000
CY2022	gtbif	Increase In Fair Value Of Investments IncreaseInFairValueOfInvestments	11651000
CY2021	gtbif	Increase In Fair Value Of Investments IncreaseInFairValueOfInvestments	-6377000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="notes_to_financial_statements" style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. NATURE OF OPERATIONS</span></p><p style="text-indent:-4.749%;padding-left:4.533%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Green Thumb Industries Inc. (“Green Thumb” or the “Company”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail stores. The Company also owns and operates retail cannabis stores that include a national chain named RISE, which sell our products and third-party products. As of December 31, 2023, Green Thumb has revenue in fourteen markets (California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,600 people and serves millions of patients and customers annually.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s registered office is located at 250 Howe Street, 20</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters is at 325 W. Huron St., Suite 700, Chicago, IL 60654.</span></p>
CY2023	gtbif	Functionalandpresentationcurrencypolicytextblock Functionalandpresentationcurrencypolicytextblock	<div style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">(c)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Functional and Presentation Currency</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s functional currency, as determined by management, is the United States (“US”</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) dollar. These consolidated financial statements are presented in U.S. dollars.</span></p>
CY2023	gtbif	Description Of Shareholding Voting Rights DescriptionOfShareholdingVotingRights	shareholding of between 20% and 50% of the voting rights
CY2023	gtbif	Noncontrollinginterestspolicytextblock Noncontrollinginterestspolicytextblock	<div style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">(f)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-controlling Interests</span></div></div><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-controlling interests (“NCI</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">”) represent equity interests owned by outside parties. NCI may be initially measured at fair value or at the NCI’s proportionate share of the recognized amounts of the acquiree’s identifiable net assets. The choice of measurement is made on a transaction by transaction basis. Green Thumb elected to measure each NCI at its proportionate share of the recognized amounts of the acquiree’s identifiable net assets. The share of net assets attributable to NCI are presented as a component of equity. Their share of net income or loss and comprehensive income or loss is recognized directly in equity. Total comprehensive income or loss of subsidiaries is attributed to the shareholders of the Company and to the NCI, even if this results in the NCI having a deficit balance.</span></p>
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1658000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	928000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	729000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	423000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	488000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	557873000
CY2023	us-gaap	Depreciation Depreciation	49949000
CY2022	us-gaap	Depreciation Depreciation	37006000
CY2021	us-gaap	Depreciation Depreciation	23250000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5467000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1419000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4744000
CY2023	gtbif	Notereceivableandinvestmentspolicytextblock Notereceivableandinvestmentspolicytextblock	<div style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">(k)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note Receivable and Investments</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Convertible notes investments and investments in equity of private companies are classified as financial assets at fair value. Upon initial recognition, the investment is recognized at fair value with directly attributable transaction costs expensed as incurred. Subsequent changes in fair value are recognized in profit or loss.</span></p>
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	31131000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	30
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	gtbif	Sales Discounted SalesDiscounted	232031000
CY2022	gtbif	Sales Discounted SalesDiscounted	167288000
CY2021	gtbif	Sales Discounted SalesDiscounted	83851000
CY2023Q4	gtbif	Customer Loyalty Program Liability CustomerLoyaltyProgramLiability	4839000
CY2022Q4	gtbif	Customer Loyalty Program Liability CustomerLoyaltyProgramLiability	4871000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10071467
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3734555
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9577947
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3734555
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5383275
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3835278
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	220325
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1001835
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	121945
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2323625
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1042199
CY2023	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	2477120
CY2022	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	1895273
CY2021	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	626930
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5467000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1419000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4744000
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	30
CY2022Q4	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1547000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3070000
CY2023Q4	gtbif	Inventory Packing And Miscellaneous InventoryPackingAndMiscellaneous	10661000
CY2022Q4	gtbif	Inventory Packing And Miscellaneous InventoryPackingAndMiscellaneous	9847000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	47029000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	57287000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	57631000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	49268000
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	3898000
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	3797000
CY2023Q4	us-gaap	Inventory Net InventoryNet	112970000
CY2022Q4	us-gaap	Inventory Net InventoryNet	115675000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	757529000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	452747000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	127290000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80702000
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	630239000
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	372045000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	687106000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	729230000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	190552000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	538678000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	729230000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	139711000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	589519000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50841000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	59658000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45208000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	31131000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50392000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50294000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	47332000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	46803000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	46803000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	297054000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	538678000
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y4M13D
CY2022Q4	us-gaap	Goodwill Goodwill	589691000
CY2023Q4	us-gaap	Goodwill Goodwill	589691000
CY2022Q1	us-gaap	Goodwill Goodwill	632849000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-9517000
CY2022Q4	us-gaap	Goodwill Goodwill	589691000
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	57372000
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	57372000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	57372000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	3012000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	3241000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	15197000
CY2023	gtbif	Debt Percentage Held By Related Parties DebtPercentageHeldByRelatedParties	0.01
CY2023	gtbif	Debt Percentage Held By Unrelated Third Parties DebtPercentageHeldByUnrelatedThirdParties	0.99
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	74169000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	94902000
CY2023	gtbif	Additional To Long Term Invesmnets AdditionalToLongTermInvesmnets	8200000
CY2022	gtbif	Additional To Long Term Invesmnets AdditionalToLongTermInvesmnets	5444000
CY2023	gtbif	Disposal Of Long Term Investments DisposalOfLongTermInvestments	-498000
CY2022	gtbif	Disposal Of Long Term Investments DisposalOfLongTermInvestments	-3571000
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-17460000
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-22606000
CY2023	us-gaap	Transfer Of Investments TransferOfInvestments	50000
CY2022	us-gaap	Transfer Of Investments TransferOfInvestments	0
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	64361000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	74169000
CY2023	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	408000
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	664000
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	422000
CY2023	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-17460000
CY2022	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-22606000
CY2021	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	6377000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-20660000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-16910000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6377000
CY2023Q4	gtbif	Investment In Non Convertible Instrument InvestmentInNonConvertibleInstrument	22214000
CY2022Q4	gtbif	Investment In Non Convertible Instrument InvestmentInNonConvertibleInstrument	22214000
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	48231000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	43985000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	34124000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M14D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11282000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y9M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y7M20D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.124
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1242
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	44070000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	42188000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	41423000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	41777000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	41227000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	319954000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	530639000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	268878000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	261761000
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5584000
CY2023Q4	us-gaap	Notes Payable NotesPayable	308523000
CY2022Q4	us-gaap	Notes Payable NotesPayable	275668000
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2996000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1037000
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	305527000
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	274631000
CY2017Q4	gtbif	Charitable Contribution Quarterly Payment CharitableContributionQuarterlyPayment	50000
CY2017	gtbif	Charitable Contribution Date Of Last Required Payment CharitableContributionDateOfLastRequiredPayment	October 2024
CY2019Q4	gtbif	Charitable Contribution Quarterly Payment CharitableContributionQuarterlyPayment	250000
CY2019	gtbif	Charitable Contribution Date Of Last Required Payment CharitableContributionDateOfLastRequiredPayment	May 2024
CY2017Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0217
CY2019Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.07
CY2021Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-04-30
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	2643000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	4268000
CY2023Q4	gtbif	Issuance Of Deferred Shares IssuanceOfDeferredShares	12973000
CY2022Q4	gtbif	Issuance Of Deferred Shares IssuanceOfDeferredShares	36211000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9577947
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26961000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2451405
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.9
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	477545
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.58
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1480340
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.86
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10071467
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.75
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M21D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22442000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3467131
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.99
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.24
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.37
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.47
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	996000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2390000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18142000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0306
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0432
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0118
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0354
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	947502
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.91
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3607667
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.87
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	483393
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.39
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	451138
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	15.17
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3620638
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.25
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.87
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.84
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.82
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28189000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27140000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19600000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	108399000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	106425000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	96749000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24674000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	36436000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	35402000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	133073000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	142861000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	132151000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10694000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-37362000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6151000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3749000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-10722000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1388000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14443000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-48084000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7539000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118630000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94777000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124612000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	156049000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	108432000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	204975000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	32770000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	22771000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	43045000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	21514000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	24077000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	31476000
CY2023	gtbif	Income Tax Reconciliation Tax Provision To Return Adjustment IncomeTaxReconciliationTaxProvisionToReturnAdjustment	-9188000
CY2022	gtbif	Income Tax Reconciliation Tax Provision To Return Adjustment IncomeTaxReconciliationTaxProvisionToReturnAdjustment	499000
CY2021	gtbif	Income Tax Reconciliation Tax Provision To Return Adjustment IncomeTaxReconciliationTaxProvisionToReturnAdjustment	971000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2082000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	497000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1836000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	49635000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	40870000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	40847000
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-27000
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-127000
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	54000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	32000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-25970000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10712000
CY2023	gtbif	Income Tax Reconciliation Change In Uncertain Tax Position IncomeTaxReconciliationChangeInUncertainTaxPosition	23362000
CY2022	gtbif	Income Tax Reconciliation Change In Uncertain Tax Position IncomeTaxReconciliationChangeInUncertainTaxPosition	30607000
CY2021	gtbif	Income Tax Reconciliation Change In Uncertain Tax Position IncomeTaxReconciliationChangeInUncertainTaxPosition	2776000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1550000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1553000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3433000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118630000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94777000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124612000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	99535000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	118176000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	148104000
CY2023Q4	gtbif	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	58591000
CY2022Q4	gtbif	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	60588000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	734000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1864000
CY2023Q4	gtbif	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	7313000
CY2022Q4	gtbif	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	7499000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	14166000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10646000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	7725000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5846000
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	8875000
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	3306000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7084000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5391000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	734000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	702000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	103754000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	94438000
CY2023Q4	gtbif	Deferred Tax Liabilities Operating Right Of Use Assets DeferredTaxLiabilitiesOperatingRightOfUseAssets	53040000
CY2022Q4	gtbif	Deferred Tax Liabilities Operating Right Of Use Assets DeferredTaxLiabilitiesOperatingRightOfUseAssets	56546000
CY2023Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-5097000
CY2022Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-4804000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	50594000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	52508000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	108731000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	113858000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4977000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	19420000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	734000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	702000
CY2023	gtbif	Operating Loss Carryforward Expiration Date OperatingLossCarryforwardExpirationDate	2031
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	43130000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	13117000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10341000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	8919000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	9531000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	823000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3193000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1100000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	17676000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	21582000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6166000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	40000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	4213000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	66492000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	43130000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	13117000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	10042000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3555000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1377000
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	14617000
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	4575000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	5565000
CY2023	gtbif	Unrecognized Tax Benefits Expected Period For Recover UnrecognizedTaxBenefitsExpectedPeriodForRecover	P12M
CY2023	gtbif	Fair Value Adjustments On Equity Investments FairValueAdjustmentsOnEquityInvestments	-17868000
CY2022	gtbif	Fair Value Adjustments On Equity Investments FairValueAdjustmentsOnEquityInvestments	-23270000
CY2021	gtbif	Fair Value Adjustments On Equity Investments FairValueAdjustmentsOnEquityInvestments	5955000
CY2023	gtbif	Fair Value Adjustments On Equity Method Investments FairValueAdjustmentsOnEquityMethodInvestments	0
CY2022	gtbif	Fair Value Adjustments On Equity Method Investments FairValueAdjustmentsOnEquityMethodInvestments	10955000
CY2021	gtbif	Fair Value Adjustments On Equity Method Investments FairValueAdjustmentsOnEquityMethodInvestments	0
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1283000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10645000
CY2023	gtbif	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	1403000
CY2022	gtbif	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	20357000
CY2021	gtbif	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	14577000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1166000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4259000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1799000
CY2023	gtbif	Other Gains OtherGains	141000
CY2022	gtbif	Other Gains OtherGains	716000
CY2021	gtbif	Other Gains OtherGains	-1009000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16207000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4499000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10677000
CY2022	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	900000
CY2023	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0
CY2023Q4	us-gaap	Notes Payable NotesPayable	308523000
CY2022Q4	us-gaap	Notes Payable NotesPayable	275668000
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2996000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1037000
CY2022	gtbif	Net Gain On Fair Value Adjustments NetGainOnFairValueAdjustments	35200000
CY2021	gtbif	Net Gain On Fair Value Adjustments NetGainOnFairValueAdjustments	11900000
CY2023	us-gaap	Revenues Revenues	1054553000
CY2022	us-gaap	Revenues Revenues	1017375000
CY2021	us-gaap	Revenues Revenues	893560000
CY2023	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	100790000
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	96664000
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	68458000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118630000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94777000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124612000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	248536000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	252388000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	275398000
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	278231000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1054553000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44202000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	41063000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	49027000
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	50340000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	184632000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9139000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	13400000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	10512000
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	3216000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	36267000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237398253
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238000135
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239459783
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236934348
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237927867
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237686092
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238423288
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	240289959
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239162831
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239827390
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	242600000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254311000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	261194000
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	259270000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1017375000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	54552000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	62263000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	48761000
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-44512000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	121064000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	28939000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	24437000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	9829000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-51227000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11978000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.1
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235838947
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236783625
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237002873
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237208543
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236713056
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238225420
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237762903
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237804799
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237208543
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238080030
CY2023	dei	Auditor Name AuditorName	Baker Tilly US, LLP
CY2023	dei	Auditor Location AuditorLocation	Chicago, Illinois

Files In Submission

Name	View Source	Status
0000950170-24-022653-index-headers.html	Edgar Link	pending
0000950170-24-022653-index.html	Edgar Link	pending
0000950170-24-022653.txt	Edgar Link	pending
0000950170-24-022653-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtbif-20231231.htm	Edgar Link	pending
gtbif-20231231.xsd	Edgar Link	pending
gtbif-ex21_1.htm	Edgar Link	pending
gtbif-ex23_1.htm	Edgar Link	pending
gtbif-ex31_1.htm	Edgar Link	pending
gtbif-ex31_2.htm	Edgar Link	pending
gtbif-ex32_1.htm	Edgar Link	pending
gtbif-ex32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gtbif-20231231_htm.xml	Edgar Link	completed
gtbif-ex4_2.htm	Edgar Link	pending
img168963129_0.jpg	Edgar Link	pending
img168963129_1.jpg	Edgar Link	pending
img168963129_2.jpg	Edgar Link	pending
img168963129_3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTBIF
Green Thumb Industries Inc. Stock $gtbif

2023 Q4 Form 10-K Financial Statement

#000095017024022653 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTBIF Green Thumb Industries Inc. Stock $gtbif

2023 Q4 Form 10-K Financial Statement

#000095017024022653 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTBIF
Green Thumb Industries Inc. Stock $gtbif